Results 71 to 80 of about 536,457 (327)

Covid-19 and marketing strategies [PDF]

open access: yes, 2022
COVID-19 is the disease caused by a new coronavirus, SARS-CoV-2. It was named a coronavirus because the virus represents crown-like spikes on the outer surface of the virus (WHO, 2020).
Harun, Amran   +2 more
core  

Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study. [PDF]

open access: yes, 2020
BackgroundAn outbreak of COVID-19 in Iran has spread throughout the country. Identifying the epidemiological characteristics of this disease will help to make appropriate decisions and thus control the epidemic. The aim of this study was characterization
Abbaszadeh, Sepideh   +19 more
core   +1 more source

A Case of Coronavirus Disease 2019 Presenting with Seizures Secondary to Cerebral Venous Sinus Thrombosis

open access: yesCase Reports in Neurology, 2020
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2. COVID-19-associated thrombotic events are recognized. A wide variety of neurological presentations have been recently documented.
Suhail Hussain   +3 more
doaj   +1 more source

Anosmia and Ageusia as the Only Indicators of Coronavirus Disease 2019 (COVID-19) [PDF]

open access: yes, 2020
The patient is a 60-year-old woman with a history of vertigo and seasonal allergies who presented to the hospital with the chief complaint of headache. Radiological findings were negative for intracranial abnormalities. The headache was due to trigeminal
Abdollahi, Shahrzad   +3 more
core   +1 more source

The aftermath of coronavirus disease of 2019: devastation or a new dawn for nephrology? [PDF]

open access: yes, 2020
The acute crisis with the coronavirus disease of 2019 (COVID-19) caused by the novel coronavirus Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) is the largest biomedical catastrophe of our lifetimes. Like so many other disasters in the past,
Agarwal, Rajiv
core   +1 more source

COVID-19 Infection: Implications for Perioperative and Critical Care Physicians. [PDF]

open access: yes, 2020
Healthcare systems worldwide are responding to Coronavirus Disease 2019 (COVID-19), an emerging infectious syndrome caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus. Patients with COVID-19 can progress from asymptomatic or
Greenland, John R   +3 more
core  

Covid-19 and its impact on digital marketing [PDF]

open access: yes, 2022
The coronavirus disease 2019 (COVID-19), is a new type of coronavirus spreading exponentially globally. It was started in December 2019 in Wuhan, China, which caused severe acute respiratory \ud syndrome coronavirus 2 (SARS-CoV-2) (Dashraath et al ...
Abdul Rashid, Umi Kartini   +5 more
core  

Vulnerability of deep neural networks for detecting COVID-19 cases from chest X-ray images to universal adversarial attacks [PDF]

open access: yes, 2020
Under the epidemic of the novel coronavirus disease 2019 (COVID-19), chest X-ray computed tomography imaging is being used for effectively screening COVID-19 patients.
Hirano, Hokuto   +2 more
core   +3 more sources

Laboratory diagnosis of coronavirus disease-2019 (COVID-19)

open access: yesClinica Chimica Acta, 2020
The outbreak of Coronavirus Disease-2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has threatened health worldwide. As of the end of 2020, there were nearly 10 million confirmed cases and nearly 5 million deaths associated with COVID-19.
Li, Chenxi   +5 more
openaire   +2 more sources

Long‐Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives This ongoing, open‐label extension study is evaluating the long‐term safety, tolerability, and efficacy of givinostat, a Class I and II histone deacetylase inhibitor, in patients with Duchenne muscular dystrophy (DMD). Methods The recruited patients completed one of two prior clinical studies (one Phase 2 and one Phase 3 [EPIDYS ...
Craig M. McDonald   +74 more
wiley   +1 more source

Home - About - Disclaimer - Privacy